
Classification of venous and lymphatic malformations according to the description of the International Society for the Study of Vascular Anomalies is based on clinical and MRI appearance. Although possible limitations exist, it should be carried out for treatment decisions. Treatment modalities include the use of sclerosing agents directly introduced by percutaneous puncture (Ethibloc, Thrombovar, Ethanol in venous malformations or Picibanil in macrocystic lymphatic malformations), laser-induced thermal therapy, surgery, or a combination of different techniques. A promising substance for treatment of venous malformations is an Ethanol mixture with Ethylcellulose at a higher viscosity, which is under evaluation in a multicenter-study.
Lymphatic System, Ethanol, Sclerotherapy, Solvents, Humans, Lymphatic Diseases, Sclerosing Solutions, Veins
Lymphatic System, Ethanol, Sclerotherapy, Solvents, Humans, Lymphatic Diseases, Sclerosing Solutions, Veins
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 10 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
